Karachi—Every four out of ten people in our country is either suffering from diabetes or is at high risk to be inflicted with it, said Dr.

Publicly-held biotechnology major Biocon Ltd on Friday announced it had entered into an agreement with the US-based $21-billion Bristol-Myers Squibb (BMS) to further develop its IN-105, an oral insulin product candidate.

Biocon will use BMS’ expertise in clinical trials and get help in redesigning Phase-II trials of the blockbuster drug. Biocon has been working on this drug since 2004 and has so far spent close to $20 million. It had started the programme by partnering US-based Nobex, but later taken control as the latter declared bankruptcy in late 2005.

The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke has been implemented in four districts of Haryana-Mewat, Ambala, Kurukshetra and Yamunanaga

New Delhi: Diabetes, traditionally linked to a rise in blood sugar level due to a combination of lifestyle and hereditary risks, may also have some connection with the brain.

New Delhi: Testing blood sugar levels will now take just about a minute, cost less than Rs 2 and require 1,000 times lesser blood than what glucose meters currently use.

Apart from increasing nutrition of schoolchildren, the move will help to boost production

The Agriculture Ministry has asked the States to include millets in the mid-day meal scheme to increase the demand for the cereal and, thereby, enhance farm incomes.Millet crops or coarse cereals are known for their high nutritional value and are effective in controlling diabetes and obesity. But the area under millets has been steadily declining though they are suited for arid and semi-arid regions, besides adaptability to moisture stress.

If you are a high-pressure executive, beware of your amygdala.